Aeterna Zentaris and Rafa Laboratories Sign Exclusive License Agreement for Zoptrex™ in Israel Aeterna Zentaris and Rafa Laboratories Sign Exclusive License Agreement for Zoptrex™ in Israel

…-the-counter (OTC) medicines, mainly proprietary formulations, as well as generic formulations, and consumer health products. With a history of over 75… Zentaris is a specialty biopharmaceutical company engaged in developing and commercializing novel treatments in oncology, endocrinology and women’s health

businesswire.com

Total Shares: 0

from Data Alerts http://ift.tt/2aFPlrU
via IFTTT

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

WordPress spam blocked by CleanTalk.